21-Hydroxy-5beta-pregnane-3,11,20-trione (BioCAD00000003210)

{$topic}

Metabolite Card

Formula: C21H30O4 (346.2144)
SMILES: C[C@]12CC(=O)[C@H]3[C@@H](CCC4CC(=O)CC[C@]34C)[C@@H]1CCC2C(=O)CO

Synonyms [en]

21-Hydroxy-5beta-pregnane-3,11,20-trione; 21-Hydroxy-5b-pregnane-3,11,20-trione; (5R,8S,9S,10S,13S,14S)-17-(2-hydroxyacetyl)-10,13-dimethyl-2,4,5,6,7,8,9,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,11-dione; 21-Hydroxy-5β-pregnane-3,11,20-trione

Reviewed

Last reviewed on 2024-06-28.

Cite this Page

21-Hydroxy-5beta-pregnane-3,11,20-trione. 数据之源，洞见之始. SMRUCC genomics institute, a synthetic life researcher from China. https://biocad_registry.innovation.ac.cn/s/(-)-arctiin (retrieved 2026-01-03) (CAD Registry RN: BioCAD00000003210). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

Note

21-Hydroxy-5b-pregnane-3,11,20-trione is a 21-hydroxy steroid.

Entity Information

DBLinks

Other DBLinks
  • CAS Registry Number: 10417-86-4
  • PubChem: 44263345
  • ChEBI: ChEBI:1298
  • ChEBI: ChEBI:172122
  • HMDB: HMDB0006756
  • LipidMaps: LMST02030196
  • KEGG: C05477
  • Metlin: METLIN_63328

Class / Ontology

Metabolic Network
ID EC Number Name
KEGG:R04842 1.1.1.50 3alpha,21-dihydroxy-5beta-pregnane-11,20-dione:NAD+ oxidoreductase (B-specific)
KEGG:R04843 1.1.1.50 3alpha,21-dihydroxy-5beta-pregnane-11,20-dione:NADP+ oxidoreductase (B-specific)
KEGG:R08994 C05490<=>C05477
View More
Organism Source

Taxonomy Source

Pathway Synthetic

pathway id name
WikiPathways:WP3604 Biochemical pathways: part I
PathBank:SMP0120690 Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH
PathBank:SMP0120858 11-beta-Hydroxylase Deficiency (CYP11B1)
PathBank:SMP0120641 Corticosterone Methyl Oxidase I Deficiency (CMO I)
PathBank:SMP0120649 Apparent Mineralocorticoid Excess Syndrome
PathBank:SMP0000373 Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
PathBank:SMP0000576 21-Hydroxylase Deficiency (CYP21)
PathBank:SMP0000718 3-beta-Hydroxysteroid Dehydrogenase Deficiency
PathBank:SMP0087238 Steroidogenesis
PathBank:SMP0120849 17-alpha-Hydroxylase Deficiency (CYP17)
PathBank:SMP0120861 Corticosterone Methyl Oxidase II Deficiency (CMO II)
PathBank:SMP0120869 3-beta-Hydroxysteroid Dehydrogenase Deficiency
PathBank:SMP0120451 Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency
PathBank:SMP0120640 21-Hydroxylase Deficiency (CYP21)
PathBank:SMP0000575 11-beta-Hydroxylase Deficiency (CYP11B1)
PathBank:SMP0000717 Apparent Mineralocorticoid Excess Syndrome
PathBank:SMP0063672 Steroidogenesis
PathBank:SMP0120672 Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia Due to 17 alpha-Hydroxylase Deficiency
PathBank:SMP0120860 Corticosterone Methyl Oxidase I Deficiency (CMO I)
PathBank:SMP0120868 Apparent Mineralocorticoid Excess Syndrome
View All Pathways